Title:Endometrial Adenofibroma in a Patient Receiving Toremifene: A Case Report
Volume: 20
Author(s): Lu Li, Gang Liu, Li-Zhao Huang and Tao Li*
Affiliation:
- Department of Radiology, Liuzhou Worker’s Hospital, Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, China
Keywords:
Endometrial adenofibroma, Breast cancer, Toremifene, Magnetic resonance image, Tumor, Surgery.
Abstract:
Introduction:
Adenofibroma is a rare benign Müllerian mixed tumor composed of epithelial and mesenchymal cells. This tumor may occasionally be associated
with toremifene therapy which is used as an adjuvant drug for breast cancer.
Case Presentation:
We describe a case of a 55-year-old woman with adenofibroma of the endometrium. This patient was receiving toremifene after surgery and
neoadjuvant chemotherapy for breast cancer. She underwent a total abdominal hysterectomy and bilateral salpingectomy. There was no evidence of
tumor residual or recurrence at 32 months of MRI follow-up.
Conclusion:
In conclusion, we report a rare case of endometrial adenofibroma in a patient receiving toremifene. It must be borne in mind that long-term
toremifene therapy may increase the frequency of endometrial neoplasms.
